SciVision Biotech Inc. (TPE:1786)

Market Cap	3.56B -44.9%
Revenue (ttm)	889.15M -0.2%
Net Income	178.11M +8.9%
EPS	2.38 +7.6%
Shares Out	74.83M
PE Ratio	20.02
Forward PE	n/a
Dividend	1.91 (4.02%)
Ex-Dividend Date	Apr 29, 2026

Volume	466,431
Open	47.55
Previous Close	43.25
Day's Range	47.55 - 47.55
52-Week Range	38.80 - 91.70
Beta	0.48
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 6, 2026

About SciVision Biotech

SciVision Biotech Inc. develops and manufactures medical-grade hyaluronic acid products in Taiwan. The company offers synovial fluid supplements, facial dermal implants, absorbable adhesion barriers, and intravesical instillation products. It also involved in international trade; wholesale of medical equipment and cosmetics; and provides management advisory services. SciVision Biotech Inc. was founded in 1990 and is based in Kaohsiung, Taiwan.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1990
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1786

Financial Performance

In 2025, SciVision Biotech's revenue was 886.62 million, an increase of 0.37% compared to the previous year's 883.31 million. Earnings were 162.34 million, a decrease of -32.99%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 30, 2026

Data Sources Report a data error